Peptomyc S.L.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study to Evaluate the Safety, PK, and Efficacy of the Myc Inhibitor OMO-103 Administered iv in Patients With PDAC (NCT06059001) | Peptomyc S.L. | 2023-08-31 |
| Phase 1/2 Study to Evaluate Safety, PK and Efficacy of the MYC-Inhibitor OMO-103 in Solid Tumours (NCT04808362) | Peptomyc S.L. | 2021-04-28 |
Track Peptomyc S.L. automatically
Every clearance here is in the API, with alerts when new ones post.